Literature DB >> 22920264

Comparison of a 2-step insulin-response test to conventional insulin-sensitivity testing in horses.

F R Bertin1, J E Sojka-Kritchevsky.   

Abstract

Equine insulin resistance is important because of its association with laminitis. The insulin-response test is described to diagnose insulin resistance in clinical settings. Practitioners may be reluctant to perform this test because of the time needed for the test and the fear of inducing hypoglycemia. The objective of the study was to compare a 2-step insulin-response test with a complete insulin-response test. A complete insulin-response test was performed on 6 insulin-resistant horses and 6 controls. A 2-step insulin-response test consisting of an intravenous injection of 0.1 IU/kg human insulin and blood glucose determination at 0 and 30 min after injection was performed on the same horses. Times to reach a 50% reduction of glucose baseline were compared between tests and horses. All the horses tolerated both tests well. No significant difference was observed between baseline glucose concentrations of insulin-resistant horses and controls (P = 0.09). Time to reach 50% reduction of glucose baseline for controls was not significantly different with the use of the complete insulin-response test or the 2-step test (P = 0.98). For insulin-resistant horses, the time to reach 50% reduction of glucose baseline with the use of the 2-step test was significantly longer than for controls (P = 0.004). With a cut-off time of 30 min, the 2-step test had the same characteristics as the complete test. The 2-step test provided a safe, rapid, and low-cost method to diagnose insulin resistance in horses in a clinical setting.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22920264     DOI: 10.1016/j.domaniend.2012.07.003

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  8 in total

1.  Comparison of the glucose and insulin responses of horses to 2 formulations of corn syrup.

Authors:  Kira Moser; Heidi Banse
Journal:  Can Vet J       Date:  2019-06       Impact factor: 1.008

Review 2.  Equine metabolic syndrome.

Authors:  R Morgan; J Keen; C McGowan
Journal:  Vet Rec       Date:  2015-08-15       Impact factor: 2.695

3.  The Effect of Fasting Duration on Baseline Blood Glucose Concentration, Blood Insulin Concentration, Glucose/Insulin Ratio, Oral Sugar Test, and Insulin Response Test Results in Horses.

Authors:  F R Bertin; S D Taylor; A W Bianco; J E Sojka-Kritchevsky
Journal:  J Vet Intern Med       Date:  2016-08-02       Impact factor: 3.333

4.  ECEIM consensus statement on equine metabolic syndrome.

Authors:  Andy E Durham; Nicholas Frank; Cathy M McGowan; Nicola J Menzies-Gow; Ellen Roelfsema; Ingrid Vervuert; Karsten Feige; Kerstin Fey
Journal:  J Vet Intern Med       Date:  2019-02-06       Impact factor: 3.333

5.  Blood glucose and insulin concentrations after alpha-2-agonists administration in horses with and without insulin dysregulation.

Authors:  Janice E Kritchevsky; Genevieve S Muir; Dakota H Z Leschke; Jack K Hodgson; Emily K Hess; Francois-Rene Bertin
Journal:  J Vet Intern Med       Date:  2020-02-26       Impact factor: 3.333

6.  Immunoreactive insulin stability in horses at risk of insulin dysregulation.

Authors:  Dakota H Leschke; Genevieve S Muir; Jack K Hodgson; Mitchell Coyle; Remona Horn; François-René Bertin
Journal:  J Vet Intern Med       Date:  2019-10-16       Impact factor: 3.333

7.  Insulin dysregulation in horses with systemic inflammatory response syndrome.

Authors:  François-René Bertin; Debra Ruffin-Taylor; Allison Jean Stewart
Journal:  J Vet Intern Med       Date:  2018-05-10       Impact factor: 3.333

8.  Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.

Authors:  Remona Horn; François-René Bertin
Journal:  J Vet Intern Med       Date:  2019-09-09       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.